Enhanced asthma-related fibroblast to myofibroblast transition is the result of profibrotic TGF-β/Smad2/3 pathway intensification and antifibrotic TGF-β/Smad1/5/(8)9 pathway impairment

Abstract Airway remodelling with subepithelial fibrosis, which abolishes the physiological functions of the bronchial wall, is a major issue in bronchial asthma. Human bronchial fibroblasts (HBFs) derived from patients diagnosed with asthma display in vitro predestination towards TGF-β1-induced fibr...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Dawid Wnuk, Milena Paw, Karolina Ryczek, Grażyna Bochenek, Krzysztof Sładek, Zbigniew Madeja, Marta Michalik
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2020
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/4e8d04ff46cd4efcaa6314b15934e936
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:4e8d04ff46cd4efcaa6314b15934e936
record_format	dspace
spelling	oai:doaj.org-article:4e8d04ff46cd4efcaa6314b15934e9362021-12-02T18:36:14ZEnhanced asthma-related fibroblast to myofibroblast transition is the result of profibrotic TGF-β/Smad2/3 pathway intensification and antifibrotic TGF-β/Smad1/5/(8)9 pathway impairment10.1038/s41598-020-73473-72045-2322https://doaj.org/article/4e8d04ff46cd4efcaa6314b15934e9362020-10-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-73473-7https://doaj.org/toc/2045-2322Abstract Airway remodelling with subepithelial fibrosis, which abolishes the physiological functions of the bronchial wall, is a major issue in bronchial asthma. Human bronchial fibroblasts (HBFs) derived from patients diagnosed with asthma display in vitro predestination towards TGF-β1-induced fibroblast-to-myofibroblast transition (FMT), a key event in subepithelial fibrosis. As commonly used anti-asthmatic drugs do not reverse the structural changes of the airways, and the molecular mechanism of enhanced asthma-related TGF-β1-induced FMT is poorly understood, we investigated the balance between the profibrotic TGF-β/Smad2/3 and the antifibrotic TGF-β/Smad1/5/9 signalling pathways and its role in the myofibroblast formation of HBF populations derived from asthmatic and non-asthmatic donors. Our findings showed for the first time that TGF-β-induced activation of the profibrotic Smad2/3 signalling pathway was enhanced, but the activation of the antifibrotic Smad1/5/(8)9 pathway by TGF-β1 was significantly diminished in fibroblasts from asthmatic donors compared to those from their healthy counterparts. The impairment of the antifibrotic TGF-β/Smad1/5/(8)9 pathway in HBFs derived from asthmatic donors was correlated with enhanced FMT. Furthermore, we showed that Smad1 silencing in HBFs from non-asthmatic donors increased the FMT potential in these cells. Additionally, we demonstrated that activation of antifibrotic Smad signalling via BMP7 or isoliquiritigenin [a small-molecule activator of the TGF-β/Smad1/5/(8)9 pathway] administration prevents FMT in HBFs from asthmatic donors through downregulation of profibrotic genes, e.g., α-SMA and fibronectin. Our data suggest that influencing the balance between the antifibrotic and profibrotic TGF-β/Smad signalling pathways using BMP7-mimetic compounds presents an unprecedented opportunity to inhibit subepithelial fibrosis during airway remodelling in asthma.Dawid WnukMilena PawKarolina RyczekGrażyna BochenekKrzysztof SładekZbigniew MadejaMarta MichalikNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-16 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Dawid Wnuk Milena Paw Karolina Ryczek Grażyna Bochenek Krzysztof Sładek Zbigniew Madeja Marta Michalik Enhanced asthma-related fibroblast to myofibroblast transition is the result of profibrotic TGF-β/Smad2/3 pathway intensification and antifibrotic TGF-β/Smad1/5/(8)9 pathway impairment
description	Abstract Airway remodelling with subepithelial fibrosis, which abolishes the physiological functions of the bronchial wall, is a major issue in bronchial asthma. Human bronchial fibroblasts (HBFs) derived from patients diagnosed with asthma display in vitro predestination towards TGF-β1-induced fibroblast-to-myofibroblast transition (FMT), a key event in subepithelial fibrosis. As commonly used anti-asthmatic drugs do not reverse the structural changes of the airways, and the molecular mechanism of enhanced asthma-related TGF-β1-induced FMT is poorly understood, we investigated the balance between the profibrotic TGF-β/Smad2/3 and the antifibrotic TGF-β/Smad1/5/9 signalling pathways and its role in the myofibroblast formation of HBF populations derived from asthmatic and non-asthmatic donors. Our findings showed for the first time that TGF-β-induced activation of the profibrotic Smad2/3 signalling pathway was enhanced, but the activation of the antifibrotic Smad1/5/(8)9 pathway by TGF-β1 was significantly diminished in fibroblasts from asthmatic donors compared to those from their healthy counterparts. The impairment of the antifibrotic TGF-β/Smad1/5/(8)9 pathway in HBFs derived from asthmatic donors was correlated with enhanced FMT. Furthermore, we showed that Smad1 silencing in HBFs from non-asthmatic donors increased the FMT potential in these cells. Additionally, we demonstrated that activation of antifibrotic Smad signalling via BMP7 or isoliquiritigenin [a small-molecule activator of the TGF-β/Smad1/5/(8)9 pathway] administration prevents FMT in HBFs from asthmatic donors through downregulation of profibrotic genes, e.g., α-SMA and fibronectin. Our data suggest that influencing the balance between the antifibrotic and profibrotic TGF-β/Smad signalling pathways using BMP7-mimetic compounds presents an unprecedented opportunity to inhibit subepithelial fibrosis during airway remodelling in asthma.
format	article
author	Dawid Wnuk Milena Paw Karolina Ryczek Grażyna Bochenek Krzysztof Sładek Zbigniew Madeja Marta Michalik
author_facet	Dawid Wnuk Milena Paw Karolina Ryczek Grażyna Bochenek Krzysztof Sładek Zbigniew Madeja Marta Michalik
author_sort	Dawid Wnuk
title	Enhanced asthma-related fibroblast to myofibroblast transition is the result of profibrotic TGF-β/Smad2/3 pathway intensification and antifibrotic TGF-β/Smad1/5/(8)9 pathway impairment
title_short	Enhanced asthma-related fibroblast to myofibroblast transition is the result of profibrotic TGF-β/Smad2/3 pathway intensification and antifibrotic TGF-β/Smad1/5/(8)9 pathway impairment
title_full	Enhanced asthma-related fibroblast to myofibroblast transition is the result of profibrotic TGF-β/Smad2/3 pathway intensification and antifibrotic TGF-β/Smad1/5/(8)9 pathway impairment
title_fullStr	Enhanced asthma-related fibroblast to myofibroblast transition is the result of profibrotic TGF-β/Smad2/3 pathway intensification and antifibrotic TGF-β/Smad1/5/(8)9 pathway impairment
title_full_unstemmed	Enhanced asthma-related fibroblast to myofibroblast transition is the result of profibrotic TGF-β/Smad2/3 pathway intensification and antifibrotic TGF-β/Smad1/5/(8)9 pathway impairment
title_sort	enhanced asthma-related fibroblast to myofibroblast transition is the result of profibrotic tgf-β/smad2/3 pathway intensification and antifibrotic tgf-β/smad1/5/(8)9 pathway impairment
publisher	Nature Portfolio
publishDate	2020
url	https://doaj.org/article/4e8d04ff46cd4efcaa6314b15934e936
work_keys_str_mv	AT dawidwnuk enhancedasthmarelatedfibroblasttomyofibroblasttransitionistheresultofprofibrotictgfbsmad23pathwayintensificationandantifibrotictgfbsmad1589pathwayimpairment AT milenapaw enhancedasthmarelatedfibroblasttomyofibroblasttransitionistheresultofprofibrotictgfbsmad23pathwayintensificationandantifibrotictgfbsmad1589pathwayimpairment AT karolinaryczek enhancedasthmarelatedfibroblasttomyofibroblasttransitionistheresultofprofibrotictgfbsmad23pathwayintensificationandantifibrotictgfbsmad1589pathwayimpairment AT grazynabochenek enhancedasthmarelatedfibroblasttomyofibroblasttransitionistheresultofprofibrotictgfbsmad23pathwayintensificationandantifibrotictgfbsmad1589pathwayimpairment AT krzysztofsładek enhancedasthmarelatedfibroblasttomyofibroblasttransitionistheresultofprofibrotictgfbsmad23pathwayintensificationandantifibrotictgfbsmad1589pathwayimpairment AT zbigniewmadeja enhancedasthmarelatedfibroblasttomyofibroblasttransitionistheresultofprofibrotictgfbsmad23pathwayintensificationandantifibrotictgfbsmad1589pathwayimpairment AT martamichalik enhancedasthmarelatedfibroblasttomyofibroblasttransitionistheresultofprofibrotictgfbsmad23pathwayintensificationandantifibrotictgfbsmad1589pathwayimpairment
_version_	1718377859191406592

Enhanced asthma-related fibroblast to myofibroblast transition is the result of profibrotic TGF-β/Smad2/3 pathway intensification and antifibrotic TGF-β/Smad1/5/(8)9 pathway impairment

Ejemplares similares